Literature DB >> 2974422

Functional interaction between B cell subpopulations defined by CD23 expression.

R J Armitage1, L K Goff.   

Abstract

Using the CD23 monoclonal antibody (mAb) MHM6 and sheep anti-mouse Ig bound to magnetic beads we have obtained highly purified populations of MHM6+ and MHM6- tonsil B cells. We have found that the increased expression of MHM6 reactivity seen on B cells after activation results from up-regulation of antigen on cells already weakly positive and not from expression of new antigen on the previously negative population. The strong proliferative responses of MHM6+ cells seen in the presence of anti-IgM (alpha mu) and interleukin 4 (IL4) or the CDw40 mAb G28-5, and with Staphylococcus aureus Cowan I (SAC), and to a lesser extent with the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA), resemble that seen among unfractionated B cells. In contrast, the MHM6- population cultured alone responds only weakly to alpha mu + G28-5 or SAC and exhibits virtually no response to alpha mu + IL4 or TPA. With all these mitogenic stimuli, tritiated thymidine uptake by the MHM6- population is augmented three- to sixfold by the addition of mitomycin C (MC)-treated MHM6+ cells. Pretreatment of cells with anti-leukocyte functional antigen 1 mAb has little effect on the subsequent proliferation of the MHM6- population but shows cell contact to be critical for the proliferation of MHM6+ cells. Such pretreatment has revealed that the functional interaction observed between MHM6+ and MHM6- cells is dependent on both cell contact and the presence of an MHM6+ cell-derived soluble component. We have found that addition of soluble CD23, purified from Epstein-Barr virus-transformed lymphoblastoid cell line supernatant, increases the proliferative response of MHM6- tonsil B cells to mitogenic stimuli in the presence of inactivated MHM6+ cells but has no effect on proliferation when MHM6+ cells are absent. By way of contrast to normal B lymphocytes, we have examined functional responses of prolymphocytic leukemia (PLL) B cells. Although these cells, when freshly isolated, show comparable levels of CD23 expression to normal B cells, this expression is not increased upon activation. In addition, in contrast to normal B cells, the PLL MHM6- population cultured alone shows a strong proliferative response to various mitogenic stimuli, comparable to that of MHM6+ or unfractionated cells, and this response is not augmented by the addition of MC-treated MHM6+ cells. Thus, a novel functional interaction is described between normal, but not leukemic, B cell populations defined by their expression of CD23.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974422     DOI: 10.1002/eji.1830181115

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Dermatology.

Authors:  M H Rustin
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

2.  Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.

Authors:  Jad Maamary; Taia T Wang; Gene S Tan; Peter Palese; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

3.  Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors.

Authors:  K Kicza; A Fischer; T Pfeil; J Bujanowski-Weber; W König
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.

Authors:  M D Mossalayi; J C Lecron; A H Dalloul; M Sarfati; J M Bertho; H Hofstetter; G Delespesse; P Debre
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

Review 5.  Is there a role for treatment of asthma with omalizumab?

Authors:  H Milgrom
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

Review 6.  Expression, regulation and function of human Fc epsilon RII (CD23) antigen.

Authors:  M Sarfati; S Fournier; C Y Wu; G Delespesse
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Soluble CD23 displays T-cell growth enhancing activity.

Authors:  J C Lecron; F Morel; J Tanzer; J Gombert; P Goube de Laforest
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Mechanism of formation of human IgE-binding factors (soluble CD23): III. Evidence for a receptor (Fc epsilon RII)-associated proteolytic activity.

Authors:  M Letellier; T Nakajima; G Pulido-Cejudo; H Hofstetter; G Delespesse
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.